BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241028
DTEND;VALUE=DATE:20241031
DTSTAMP:20260515T144703
CREATED:20240718T090741Z
LAST-MODIFIED:20240924T114834Z
UID:39393-1730073600-1730332799@www.pharmajournalist.com
SUMMARY:Cell & Gene Therapy Regulatory Affairs Summit
DESCRIPTION:𝘞𝘢𝘯𝘵 𝘵𝘰 𝘜𝘯𝘥𝘦𝘳𝘴𝘵𝘢𝘯𝘥 𝘎𝘶𝘪𝘥𝘢𝘯𝘤𝘦\, 𝘚𝘵𝘳𝘦𝘢𝘮𝘭𝘪𝘯𝘦 𝘚𝘶𝘣𝘮𝘪𝘴𝘴𝘪𝘰𝘯𝘴\, & 𝘖𝘣𝘵𝘢𝘪𝘯 𝘈𝘱𝘱𝘳𝘰𝘷𝘢𝘭? \nThe knowledge and connections you gain at the 𝗖𝗲𝗹𝗹 & 𝗚𝗲𝗻𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗔𝗳𝗳𝗮𝗶𝗿𝘀 𝗦𝘂𝗺𝗺𝗶𝘁 will make the difference between success and delay in your IND and BLA applications. You’ll hear from top regulatory experts like David Uguen (𝗢𝗿𝗰𝗵𝗮𝗿𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀)\, Shirley Bartido (𝗧𝗮𝗸𝗲𝗱𝗮 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀)\, Yao-Yao Zhu (𝗔𝘀𝘁𝗿𝗮𝗭𝗲𝗻𝗲𝗰𝗮)\, and many more. \n  \n𝗘𝘅𝗽𝗹𝗼𝗿𝗲 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗯𝗿𝗼𝗰𝗵𝘂𝗿𝗲 𝗵𝗲𝗿𝗲 – https://ter.li/8bp1bf \nIn the fast-evolving world of cell and gene therapy\, staying ahead of regulatory changes is critical. The stakes are high\, and your applications need to be flawless to speed up approval and bring life-saving therapies to patients faster. \nThe 𝗖𝗲𝗹𝗹 & 𝗚𝗲𝗻𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗔𝗳𝗳𝗮𝗶𝗿𝘀 𝗦𝘂𝗺𝗺𝗶𝘁 will offer you the chance to: \n\nStay updated on evolving regulatory guidance\nLearn from real-world case studies\nExplore new CMC guidance\n\n… and more! \n𝗦𝗲𝗲 𝗮𝗹𝗹 𝗼𝗳 𝘄𝗵𝗮𝘁 𝘁𝗵𝗶𝘀 𝗲𝘃𝗲𝗻𝘁 𝗵𝗮𝘀 𝘁𝗼 𝗼𝗳𝗳𝗲𝗿 𝗶𝗻 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗴𝗲𝗻𝗱𝗮 – https://ter.li/8bp1bf \nDon’t miss out on your chance to navigate the complex regulatory landscape and accelerate your therapeutic pipelines at this meeting!
URL:http://www.pharmajournalist.com/event/cell-gene-therapy-regulatory-affairs-summit/
LOCATION:Washington Marriott Capitol Hill\, 175 L St NE\, Washington\, WA\, 20002\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241028
DTEND;VALUE=DATE:20241101
DTSTAMP:20260515T144703
CREATED:20240807T112944Z
LAST-MODIFIED:20240807T113009Z
UID:39511-1730073600-1730419199@www.pharmajournalist.com
SUMMARY:7th TPD & Induced Proximity Summit
DESCRIPTION:With a flurry of high capital collaborations and partnership deals from the likes of C4T\, Merck KgGA\, Monte Rosa\, Proxygen\, Orum\, and momentum building in clinic with BTK degraders\, ER degraders and many more assets. It has never been more import to re-join forces at the 7th TPD & Induced Proximity Summit\, the longest standing and most comprehensive protein degradation and proximity based conference. \nSpanning foundational research and discovery\, through to IND-filing and clinical trials\, this is the world’s definitive meeting to discuss opportunities and challenges the TPD & Induced Proximity field must address to expand the target space and facilitate the discovery and development of therapeutically relevant degraders\, blockers\, stabilizers and inducers of protein-protein interactions. Whether you’re entering the space for the first time or a well-seasoned TPD veteran\, this forum will equip you with the knowhow and connections to make rapid advances in your work. \nThe 85+ industry expert speakers include: \n\nAlessio Ciulli\, Founder & Director\, Centre for Targeted Protein Degradation (University of Dundee)\nStuart Schreiber\, Founding Chief Executive Officer\, Arena Bioworks\nSharon Townson\, Chief Scientific Officer\, Monte Rosa Therapeutics\nNello Mainolfi\, Founder\, President & Chief Executive Officer\, Kymera Therapeutics\nAdrian Gottschalk\, Chief Executive Officer\, Foghorn Therapeutics\nAndrew Hirsch\, Chief Executive Officer\, C4 Therapeutics\nArthur T. Sands\, Chief Executive Officer\, Nurix Therapeutics\nChinatsu Sakata-Sakur\, Vice President\, Astellas Pharma\n\nAssembling over 500 TPD & Induced Proximity enthusiasts from across every corner of the landscape\, we have left no stone unturned to deliver the full breadth and depth of protein degradation and modulation research with SureTACs\, EpiTACs\, RIPTACs\, Molecular Gates\, and so much more. \nView the agenda here: https://ter.li/8nvx3c
URL:http://www.pharmajournalist.com/event/7th-tpd-induced-proximity-summit/
LOCATION:The Westin Copley Place\, 10 Huntington Avenue\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR